Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations)

References

• Gillberg C. The essence in child psychiatry: early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Res Dev Disabil. 2010;31(6):1543–1551. doi:10.1016/j.ridd.2010.06.002
   PubMed Web of Science ®Google Scholar
• Gillberg C. The Essence of Autism and Other Neurodevelopmental Conditions. Rethinking Co-Morbidities, Assessment, and Intervention. Jessica Kingsley Publishers; 2021.
   Google Scholar
• Morris-Rosendahl DJ, Crocq MA. Neurodevelopmental disorders-The history and future of a diagnostic concept. Dialogues Clin Neurosci. 2020;22:65–72.
   PubMed Web of Science ®Google Scholar
• Ibrahim K, Sukhodolsky D. Rdoc and autism. In: Encyclopedia of Autism Spectrum Disorders. New York: Springer; 2018.
   Google Scholar
• Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (rdoc): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–751.
   PubMed Web of Science ®Google Scholar
• Brandeis D, Loo S, McLoughlin G, Heinrich H, Banaschewski T. Neurophysiology. In: Banaschewski T, Coghill D, Zuddas A, editors. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford University Press; 2018.
   Google Scholar
• Rohde L, Kieling C, Salum G. Current diagnostic criteria dsm, icd, and future perspectives. In: Banaschewski T, Coghill D, Zuddas A, editors. Oxford Textbook of Attention Deficit Hyperactivity Disorder. Oxford University Press; 2018.
   Google Scholar
• National Institute of Mental Health. Definitions of the RDoC Domains and Constructs. Available from: https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc. Accessed September 17, 2022.
   Google Scholar
• Stahl SM. Deconstructing psychiatric disorders, part 2: an emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist. J Clin Psychiatry. 2003;64:1145–1146.
   Web of Science ®Google Scholar
• Stahl S, Mignon L. Stahl’s Illustrated Attention Deficit Hyperactivity Disorder. Cambridge University Press; 2009.
   Google Scholar
• Gillberg C. ESSENCE samlar diagnoserna till en helhet [ESSENCE gathers the diagnoses into a whole]. Lakartidningen. 2014;111(39):1643–1646. Swedish.
   Google Scholar
• Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review. Brain Circ. 2020;6(2):70–80. doi:10.4103/bc.bc_42_19
   PubMedGoogle Scholar
• Baykal S, Albayrak Y, Durankus F, et al. Decreased serum orexin a levels in drug-naive children with attention deficit and hyperactivity disorder. Neurol Sci. 2019;40(3):593–602. doi:10.1007/s10072-018-3692-8
   Web of Science ®Google Scholar
• Cortese S, Konofal E, Lecendreux M. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role? Med Hypotheses. 2008;71(5):770–775. doi:10.1016/j.mehy.2008.06.017
   PubMed Web of Science ®Google Scholar
• Marotta R, Risoleo MC, Messina G, et al. The neurochemistry of autism. Brain Sci. 2020;10(3):163. doi:10.3390/brainsci10030163
   PubMed Web of Science ®Google Scholar
• Kobylinska L, Panaitescu AM, Gabreanu G, et al. Plasmatic levels of neuropeptides, including oxytocin, in children with autism spectrum disorder, correlate with the disorder severity. Acta Endocrinol. 2019;5:16–24.
   Google Scholar
• Kohyama J. Possible neuronal mechanisms of sleep disturbances in patients with autism spectrum disorders and attention-deficit/hyperactivity disorder. Med Hypotheses. 2016;97:131–133.
   Web of Science ®Google Scholar
• Messina A, Monda V, Sessa F, et al. Sympathetic, metabolic adaptations, and oxidative stress in autism spectrum disorders: how far from physiology? Front Physiol. 2018;9:261.
   Web of Science ®Google Scholar
• Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387:1240–1250.
   PubMed Web of Science ®Google Scholar
• Heidbreder R. ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis. Atten Defic Hyperact Disord. 2015;7:249–269.
   PubMedGoogle Scholar
• American Psychiatric A. Diagnostic and Statistical Manual of Mental Disorders (Dsm-5^®). Washington, United States: American Psychiatric Publishing; 2013.
   Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 11th ed. World Health Organization; 2019. Available from https://icd.who.int/en. Accessed September 17, 2022.
   Google Scholar
• Musser ED, Raiker JS. Attention-deficit/hyperactivity disorder: an integrated developmental psychopathology and research domain criteria (rdoc) approach. Compr Psychiatry. 2019;90:65–72.
   PubMed Web of Science ®Google Scholar
• Chieffi S, Carotenuto M, Monda V, et al. Orexin system: the key for a healthy life. Front Physiol. 2017;8:357.
   PubMed Web of Science ®Google Scholar
• Seigneur E, de Lecea L. Hypocretin (orexin) replacement therapies. Med Drug Discov. 2020;8:100070.
   Google Scholar
• Stahl S. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th ed. Cambridge university press; 2019.
   Google Scholar
• Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): the ultimate translational neuropeptides. J Intern Med. 2022;291:533–556.
   Web of Science ®Google Scholar
• Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology. 2020;167:107993.
   Web of Science ®Google Scholar
• Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology. 2001;142(8):3324–3431.
   PubMed Web of Science ®Google Scholar
• Kukkonen JP, Leonard CS. Orexin/hypocretin receptor signalling cascades. Br J Pharmacol. 2014;171:314–331.
   PubMed Web of Science ®Google Scholar
• Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol. 2014;171:294–313.
   PubMed Web of Science ®Google Scholar
• Alain C, Pascal N, Valérie G, Thierry V. Orexins/hypocretins and cancer: a neuropeptide as emerging target. Molecules. 2021;26:4849.
   Web of Science ®Google Scholar
• Zhang XY, Yu L, Zhuang QX, Zhu JN, Wang JJ. Central functions of the orexinergic system. Neurosci Bull. 2013;29:355–365.
   Web of Science ®Google Scholar
• Summers CH, Yaeger JDW, Staton CD, Arendt DH, Summers TR. Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: potential for therapy. Brain Res. 2020;1731:146085.
   Web of Science ®Google Scholar
• Higgins E, George M. The Neuroscience of Clinical Psychiatry: The Pathophysiology of Behavior and Mental Illness. 3rd ed. Philadelphia: Wolter Kluwer; 2019.
   Google Scholar
• Stahl S, Morrissette D. Stahl’s Illustrated Sleep and Wake Disorders. Cambridge University Press; 2016.
   Google Scholar
• Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2011;51:243–266.
   PubMed Web of Science ®Google Scholar
• Toor B, Ray LB, Pozzobon A, Fogel SM. Sleep, orexin and cognition. Front Neurol Neurosci. 2021;45:38–51.
   PubMedGoogle Scholar
• Iranzo A. Sleep and neurological autoimmune diseases. Neuropsychopharmacology. 2020;45:129–140.
   Web of Science ®Google Scholar
• Peerboom C, Wierenga CJ. The postnatal gaba shift: a developmental perspective. Neurosci Biobehav Rev. 2021;124:179–192.
   Web of Science ®Google Scholar
• Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev. 2001;65:21–37.
   PubMed Web of Science ®Google Scholar
• Purkayastha P, Malapati A, Yogeeswari P, Sriram D. A review on gaba/glutamate pathway for therapeutic intervention of asd and ADHD. Curr Med Chem. 2015;22(15):1850–1859.
   Web of Science ®Google Scholar
• Bonnavion P, Mickelsen LE, Fujita A, de Lecea L, Jackson AC. Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol. 2016;594:6443–6462.
   PubMed Web of Science ®Google Scholar
• Mahler SV, Moorman DE, Smith RJ, James MH, Aston-Jones G. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci. 2014;17:1298–1303.
   PubMed Web of Science ®Google Scholar
• Faesel N, Kolodziejczyk MH, Koch M, Fendt M. Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear. Brain Res. 2021;1751:147199.
   Web of Science ®Google Scholar
• Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev. 2015;35:152–197.
   PubMed Web of Science ®Google Scholar
• Mullington JM, Cunningham TJ, Haack M, Yang H. Causes and consequences of chronic sleep deficiency and the role of orexin. Front Neurol Neurosci. 2021;45:128–138.
   Google Scholar
• BaHammam AS, Alnakshabandi K, Pandi-Perumal SR. Neuropsychiatric correlates of narcolepsy. Curr Psychiatry Rep. 2020;22:36.
   Web of Science ®Google Scholar
• Abounoori M, Maddah MM, Akbari E, Houshmand G, Ardeshiri MR. The effect of orexin receptor antagonism on quinpirole-induced compulsive-like checking behavior in rats. Neurotox Res. 2020;38:18–26.
   Web of Science ®Google Scholar
• Plazzi G, Pizza F, Palaia V, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain. 2011;134:3477–3489.
   Web of Science ®Google Scholar
• Hu B, Yang N, Qiao QC, Hu ZA, Zhang J. Roles of the orexin system in central motor control. Neurosci Biobehav Rev. 2015;49:43–54.
   Web of Science ®Google Scholar
• Kobayashi M, Nomura M, Fujihara H, et al. Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat. Peptides. 2009;30:2348–2356.
   Web of Science ®Google Scholar
• Clark IA, Vissel B. Inflammation-sleep interface in brain disease: tnf, insulin, orexin. J Neuroinflammation. 2014;11:51.
   PubMed Web of Science ®Google Scholar
• Tsuchimine S, Hattori K, Ota M, et al. Reduced plasma orexin-A levels in patients with bipolar disorder. Neuropsychiatr Dis Treat. 2019;15:2221–2230.
   Web of Science ®Google Scholar
• Li H, Lu J, Li S, et al. Increased hypocretin (orexin) plasma level in depression, bipolar disorder patients. Front Psychiatry. 2021;12:676336.
   Web of Science ®Google Scholar
• Mogavero MP, Silvani A, DelRosso LM, Salemi M, Ferri R. Focus on the complex interconnection between cancer, narcolepsy and other neurodegenerative diseases: a possible case of orexin-dependent inverse comorbidity. In: Cancers; 2021:13.
   Google Scholar
• Kawabe K, Horiuchi F, Ochi M, Nishimoto K, Ueno SI, Oka Y. Suvorexant for the treatment of insomnia in adolescents. J Child Adolesc Psychopharmacol. 2017;27:792–795.
   PubMed Web of Science ®Google Scholar
• Bruni O, Angriman M, Melegari MG, Ferri R. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opin Pharmacother. 2019;20:2257–2271.
   PubMed Web of Science ®Google Scholar
• Shariq AS, Rosenblat JD, Alageel A, et al. Evaluating the role of orexins in the pathophysiology and treatment of depression: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:1–7.
   PubMed Web of Science ®Google Scholar
• Soya S, Takahashi TM, McHugh TJ, et al. Orexin modulates behavioral fear expression through the locus coeruleus. Nat Commun. 2017;8:1606.
   Web of Science ®Google Scholar
• Khairuddin S, Aquili L, Heng BC, Hoo TLC, Wong KH, Lim LW. Dysregulation of the orexinergic system: a potential neuropeptide target in depression. Neurosci Biobehav Rev. 2020;118:384–396.
   PubMed Web of Science ®Google Scholar
• Gentile TA, Simmons SJ, Watson MN, et al. Effects of suvorexant, a dual orexin/hypocretin receptor antagonist, on impulsive behavior associated with cocaine. Neuropsychopharmacology. 2018;43:1001–1009.
   Web of Science ®Google Scholar
• Taylor JL, Corbett BA. A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders. Psychoneuroendocrinology. 2014;49:207–228.
   PubMed Web of Science ®Google Scholar
• Buske-Kirschbaum A, Trikojat K, Tesch F, et al. Altered hypothalamus-pituitary-adrenal axis function: a relevant factor in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder? Psychoneuroendocrinology. 2019;105:178–186.
   Web of Science ®Google Scholar
• Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G. Brain “fog”, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci. 2015;9:225.
   PubMed Web of Science ®Google Scholar
• Kleberg JL, Frick MA, Brocki KC. Increased pupil dilation to happy faces in children with hyperactive/impulsive symptoms of ADHD. Dev Psychopathol. 2021;33:767–777.
   Web of Science ®Google Scholar
• Anderson CJ, Colombo J. Larger tonic pupil size in young children with autism spectrum disorder. Dev Psychobiol. 2009;51:207–211.
   Web of Science ®Google Scholar
• de Vries L, Fouquaet I, Boets B, Naulaers G, Steyaert J. Autism spectrum disorder and pupillometry: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;120:479–508.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Saito YC, Yanagisawa M. Interaction between orexin neurons and monoaminergic systems. Front Neurol Neurosci. 2021;45:11–21.
   Google Scholar
• Knez R. Commentary on the paper by Gagliano et al: artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (pans): from sleep alteration to “brain fog” [letter]. Nat Sci Sleep. 2021;13:1687–1688.
   Web of Science ®Google Scholar
• Schreyer S, Buttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience. 2009;164:629–640.
   Web of Science ®Google Scholar
• Albajara Saenz A, Villemonteix T, Van Schuerbeek P, et al. Motor abnormalities in attention-deficit/hyperactivity disorder and autism spectrum disorder are associated with regional grey matter volumes. Front Neurol. 2021;12:666980.
   Web of Science ®Google Scholar
• Mokobane M, Pillay BJ, Meyer A. Fine motor deficits and attention deficit hyperactivity disorder in primary school children. S Afr J Psychiatr. 2019;25:1232.
   Web of Science ®Google Scholar
• Jasmin E, Couture M, McKinley P, Reid G, Fombonne E, Gisel E. Sensori-motor and daily living skills of preschool children with autism spectrum disorders. J Autism Dev Disord. 2009;39:231–241.
   PubMed Web of Science ®Google Scholar
• Cardon GJ. Neural correlates of sensory abnormalities across developmental disabilities. Int Rev Res Dev Disabil. 2018;55:83–143.
   PubMed Web of Science ®Google Scholar
• Fuermaier ABM, Hupen P, De Vries SM, et al. Perception in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2018;10:21–47.
   PubMedGoogle Scholar
• Sweigert JR, St John T, Begay KK, et al. Characterizing olfactory function in children with autism spectrum disorder and children with sensory processing dysfunction. Brain Sci. 2020;10:362.
   Web of Science ®Google Scholar
• Siqueiros Sanchez M, Falck-Ytter T, Kennedy DP, et al. Volitional eye movement control and ADHD traits: a twin study. J Child Psychol Psychiatry. 2020;61:1309–1316.
   PubMed Web of Science ®Google Scholar
• Howard PL, Zhang L, Benson V. What can eye movements tell us about subtle cognitive processing differences in autism? Vision. 2019;3:22.
   Google Scholar
• Burdakov D. Subsecond ensemble dynamics of orexin neurons link sensation and action. Front Neurol Neurosci. 2021;45:52–60.
   Google Scholar
• Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM. A role for hypocretin (orexin) in male sexual behavior. J Neurosci. 2007;27:2837–2845.
   PubMed Web of Science ®Google Scholar
• Caillol M, Aioun J, Baly C, Persuy MA, Salesse R. Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally. Brain Res. 2003;960:48–61.
   Web of Science ®Google Scholar
• Filardi M, Pizza F, Tonetti L, Antelmi E, Natale V, Plazzi G. Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency. PLoS One. 2017;12:e0182085.
   Web of Science ®Google Scholar
• Merlo Pich E, Melotto S. Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use. Front Neurosci. 2014;8:26.
   Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Newcorn JH, et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry. 2011;16:1147–1154.
   PubMed Web of Science ®Google Scholar
• Supekar K, Kochalka J, Schaer M, et al. Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism. Brain. 2018;141:2795–2805.
   Web of Science ®Google Scholar
• Clements CC, Zoltowski AR, Yankowitz LD, Yerys BE, Schultz RT, Herrington JD. Evaluation of the social motivation hypothesis of autism: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75:797–808.
   PubMed Web of Science ®Google Scholar
• Kohls G, Antezana L, Mosner MG, Schultz RT, Yerys BE. Altered reward system reactivity for personalized circumscribed interests in autism. Mol Autism. 2018;9:9.
   PubMed Web of Science ®Google Scholar
• Mayes SD, Zickgraf H. Atypical eating behaviors in children and adolescents with autism, ADHD, other disorders, and typical development. Res Autism Spect Dis. 2019;64:76–83.
   Web of Science ®Google Scholar
• Curtin C, Pagoto S. The association between ADHD and eating disorders/pathology in adolescents: a systematic review. Open J Epidemiol. 2013;2013. doi:10.4236/ojepi.2013.34028
   Google Scholar
• Martins-Silva T, Vaz JDS, Genro JP, et al. Obesity and ADHD: exploring the role of body composition, BMI polygenic risk score, and reward system genes. J Psychiatr Res. 2021;136:529–536.
   Web of Science ®Google Scholar
• Tyree SM, Borniger JC, de Lecea L. Hypocretin as a hub for arousal and motivation. Front Neurol. 2018;9:413.
   Web of Science ®Google Scholar
• Choi DL, Davis JF, Fitzgerald ME, Benoit SC. The role of orexin-A in food motivation, reward-based feeding behavior and food-induced neuronal activation in rats. Neuroscience. 2010;167:11–20.
   Web of Science ®Google Scholar
• Mavanji V, Butterick TA, Duffy CM, Nixon JP, Billington CJ, Kotz CM. Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice. Neurobiol Learn Mem. 2017;146:21–30.
   Web of Science ®Google Scholar
• Barson JR. Orexin/hypocretin and dysregulated eating: promotion of foraging behavior. Brain Res. 2020;1731:145915.
   Web of Science ®Google Scholar
• Wolfe FH, Auzias G, Deruelle C, Chaminade T. Focal atrophy of the hypothalamus associated with third ventricle enlargement in autism spectrum disorder. Neuroreport. 2015;26:1017–1022.
   Web of Science ®Google Scholar
• Caria A, Ciringione L, Falco S. Morphofunctional alterations of the hypothalamus and social behavior in autism spectrum disorders. Brain Sci. 2020;10:435.
   Web of Science ®Google Scholar
• Mayes SD, Calhoun SL, Aggarwal R, et al. Unusual fears in children with autism. Res Autism Spect Dis. 2013;7:151–158.
   Web of Science ®Google Scholar
• Spencer AE, Marin MF, Milad MR, et al. Abnormal fear circuitry in attention deficit hyperactivity disorder: a controlled magnetic resonance imaging study. Psychiatry Res Neuroimaging. 2017;262:55–62.
   Web of Science ®Google Scholar
• Reppucci CJ, Gergely CK, Bredewold R, Veenema AH. Involvement of orexin/hypocretin in the expression of social play behaviour in juvenile rats. Int JPlay. 2020;9(1):108–127. doi:10.1080/21594937.2020.1720132
   Web of Science ®Google Scholar
• Sears RM, Fink AE, Wigestrand MB, Farb CR, de Lecea L, Ledoux JE. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A. 2013;110(50):20260–20265. doi:10.1073/pnas.1320325110
   Web of Science ®Google Scholar
• Dustrude ET, Caliman IF, Bernabe CS, et al. Orexin depolarizes central amygdala neurons via orexin receptor 1, phospholipase c and sodium-calcium exchanger and modulates conditioned fear. Front Neurosci. 2018;12:934. doi:10.3389/fnins.2018.00934
   PubMed Web of Science ®Google Scholar
• Quaedackers L, van Gilst MM, van Mierlo P, et al. Impaired social functioning in children with narcolepsy. Sleep. 2019;42(2):zsy228. doi:10.1093/sleep/zsy228
   Web of Science ®Google Scholar
• Wang Y, Zhang Y-B, Liu -L-L, et al. A meta-analysis of working memory impairments in autism spectrum disorders. Neuropsychol Rev. 2017;27(1):46–61. doi:10.1007/s11065-016-9336-y
   PubMed Web of Science ®Google Scholar
• Durairaja A, Fendt M. Orexin deficiency modulates cognitive flexibility in a sex-dependent manner. Genes Brain Behav. 2021;20(3):e12707. doi:10.1111/gbb.12707
   Web of Science ®Google Scholar
• Wainstein G, Rojas-Libano D, Crossley NA, Carrasco X, Aboitiz F, Ossandon T. Pupil size tracks attentional performance in attention-deficit/hyperactivity disorder. Sci Rep. 2017;7(1):8228. doi:10.1038/s41598-017-08246-w
   Web of Science ®Google Scholar
• Deumer U-S, Varesi A, Floris V, et al. Myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs): an overview. J Clin Med. 2021;10(20):4786. doi:10.3390/jcm10204786
   Web of Science ®Google Scholar
• Matsuki T, Nomiyama M, Takahira H, et al. Selective loss of GABA B receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci U S A. 2009;106(11):4459–4464. doi:10.1073/pnas.0811126106
   Web of Science ®Google Scholar
• Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004;24(9):1177–1185. doi:10.1592/phco.24.13.1177.38089
   PubMed Web of Science ®Google Scholar
• Bassetti CLA, Adamantidis A, Burdakov D, et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15(9):519–539. doi:10.1038/s41582-019-0226-9
   PubMed Web of Science ®Google Scholar
• Kim J, Lee G-H, Sung SM, Jung DS, Pak K. Prevalence of attention deficit hyperactivity disorder symptoms in narcolepsy: a systematic review. Sleep Med. 2020;65:84–88. doi:10.1016/j.sleep.2019.07.022
   PubMed Web of Science ®Google Scholar
• Lecendreux M, Lavault S, Lopez R, et al. Attention-deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: a cross-sectional study. Sleep. 2015;38(8):1285–1295. doi:10.5665/sleep.4910
   PubMed Web of Science ®Google Scholar
• Wilenius L, Partinen M. Attention-deficit/hyperactivity disorder patients may have undiagnosed narcolepsy. Cureus. 2020;12(6):e8436. doi:10.7759/cureus.8436
   Web of Science ®Google Scholar
• Takahashi N, Nishimura T, Harada T, et al. Polygenic risk score analysis revealed shared genetic background in attention deficit hyperactivity disorder and narcolepsy. Transl Psychiatry. 2020;10(1):284. doi:10.1038/s41398-020-00971-7
   Web of Science ®Google Scholar
• Posar A, Visconti P, Blunda V, Pizza F, Plazzi G. Autism spectrum disorder and narcolepsy: a possible connection that deserves to be investigated. Front Psychiatry. 2020;11:265. doi:10.3389/fpsyt.2020.00265
   Web of Science ®Google Scholar
• Vaughan S, Failla MD, Poole HM, et al. Pain processing in psychiatric conditions: a systematic review. Rev General Psychol. 2019;23(3):336–358. doi:10.1177/1089268019842771
   Web of Science ®Google Scholar
• Kang X, Tang H, Liu Y, Yuan Y, Wang M. Research progress on the mechanism of orexin in pain regulation in different brain regions. Open Life Sci. 2021;16(1):46–52. doi:10.1515/biol-2021-0001
   PubMed Web of Science ®Google Scholar
• Razavi BM, Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed Pharmacother. 2017;90:187–193. doi:10.1016/j.biopha.2017.03.053
   PubMed Web of Science ®Google Scholar
• Roehrs T, Withrow D, Koshorek G, Verkler J, Bazan L, Roth T. Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo. J Clin Sleep Med. 2020;16(3):415–421. doi:10.5664/jcsm.8220
   PubMed Web of Science ®Google Scholar
• Montefusco-Siegmund R, Schwalm M, Rosales Jubal E, Devia C, Egana JI, Maldonado PE. Alpha EEG activity and pupil diameter coupling during inactive wakefulness in humans. eNeuro. 2022;9(2). doi:10.1523/ENEURO.0060-21.2022
   Web of Science ®Google Scholar
• Dichter GS, Rodriguez-Romaguera J. Anhedonia and Hyperhedonia in Autism and Related Neurodevelopmental Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg; 2022:1–18.
   Google Scholar
• Nazar BP, Bernardes C, Peachey G, Sergeant J, Mattos P, Treasure J. The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Int J Eat Disord. 2016;49(12):1045–1057. doi:10.1002/eat.22643
   Web of Science ®Google Scholar
• Svedlund NE, Norring C, Ginsberg Y, von Hausswolff-Juhlin Y. Behandling av ätstörningar vid samtidiga ADHD-symptom: Observerat samband kan ge nya möjligheter till medicinering, främst av Bulimia nervosa-men ännu finns kunskapsluckor [Treatment of eating disorders with concurrent ADHD symptoms: knowledge, knowledge gaps and clinical implications]. Lakartidningen. 2019;17:116. Swedish.
   Google Scholar
• Koomar T, Thomas TR, Pottschmidt NR, Lutter M, Michaelson JJ. Estimating the prevalence and genetic risk mechanisms of arfid in a large autism cohort. Front Psychiatry. 2021;12:668297. doi:10.3389/fpsyt.2021.668297
   Web of Science ®Google Scholar
• Råstam M, Täljemark J, Tajnia A, et al. Eating problems and overlap with ADHD and autism spectrum disorders in a nationwide twin study of 9- and 12-year-old children. ScientificWorldJournal. 2013;2013:1–7. doi:10.1155/2013/315429
   Web of Science ®Google Scholar
• Hölcke M, Marcus C, Gillberg C, Fernell E. Paediatric obesity: a neurodevelopmental perspective. Acta Paediatrica. 2008;97(6):819–821. doi:10.1111/j.1651-2227.2008.00816.x
   Web of Science ®Google Scholar
• Sammels O, Karjalainen L, Dahlgren J, Wentz E. Autism spectrum disorder and obesity in children: a systematic review and meta-analysis. Obes Facts. 2022;15(3):305–320. doi:10.1159/000523943
   Web of Science ®Google Scholar
• Fast K, Bjork A, Strandberg M, Johannesson E, Wentz E, Dahlgren J. Half of the children with overweight or obesity and attention-deficit/hyperactivity disorder reach normal weight with stimulants. Acta Paediatr. 2021;110(10):2825–2832. doi:10.1111/apa.15881
   Web of Science ®Google Scholar
• Adeghate E, Lotfy M, D’Souza C, Alseiari S, Alsaadi A, Qahtan S. Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin. Diabetes Metabol Res Rev. 2020;36(3):e3229. doi:10.1002/dmrr.3229
   Web of Science ®Google Scholar
• Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA. Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults. Neuropsychiatr Dis Treat. 2018;14:2379–2387. doi:10.2147/NDT.S170645
   Web of Science ®Google Scholar
• Sternat T, KAtzman M. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsych Dis Treat. 2016;12:2149–2164. doi:10.2147/NDT.S111818
   PubMed Web of Science ®Google Scholar
• Pizzagalli DA, Jahn AL, O’Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry. 2005;57(4):319–327. doi:10.1016/j.biopsych.2004.11.026
   PubMed Web of Science ®Google Scholar
• Meinzer MC, Pettit J, Leventhal AM, Hill RM. Explaining the covariance between attention-deficit hyperactivity disorder symptoms and depressive symptoms: the role of hedonic responsivity. J Clin Psychol. 2012;68(10):1111–1121. doi:10.1002/jclp.21884
   PubMed Web of Science ®Google Scholar
• Novacek DM, Gooding DC, Pflum MJ. Hedonic capacity in the broader autism phenotype: should social anhedonia be considered a characteristic feature? Front Psychol. 2016;7:666. doi:10.3389/fpsyg.2016.00666
   Web of Science ®Google Scholar
• Billones RR, Kumar S, Saligan LN. Disentangling fatigue from anhedonia: a scoping review. Transl Psychiatry. 2020;10(1):273. doi:10.1038/s41398-020-00960-w
   PubMed Web of Science ®Google Scholar
• Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron. 2005;46(5):787–798. doi:10.1016/j.neuron.2005.04.035
   PubMed Web of Science ®Google Scholar
• Fronczek R, Overeem S, Reijntjes R, Lammers GJ, van Dijk JG, Pijl H. Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy. J Clin Sleep Med. 2008;4(03):248–254. doi:10.5664/jcsm.27188
   Google Scholar
• Schuchardt K, Gebhardt M, Mäehler C. Working memory functions in children with different degrees of intellectual disability. J Intellect Disabil Res. 2010;54(4):346–353. doi: 10.1111/j.1365-2788.2010.01265.x.
   Google Scholar
• Alloway TP. Working memory and executive function profiles of individuals with borderline intellectual functioning. J Intellect Disabil Res. 2010;54(5):448–456. doi:10.1111/j.1365-2788.2010.01281.x
   PubMed Web of Science ®Google Scholar
• Becker S, Sharma MJ, Callahan BL. ADHD and neurodegenerative disease risk: a critical examination of the evidence. Front Aging Neurosci. 2022;13:826213. doi:10.3389/fnagi.2021.826213
   Web of Science ®Google Scholar
• Zhang L, Du Rietz E, Kuja‐Halkola R, et al. Attention-deficit/hyperactivity disorder and Alzheimer’s disease and any dementia: a multi-generation cohort study in Sweden. Alzheimers Dement. 2022;18(6):1155–1163. doi:10.1002/alz.12462
   Web of Science ®Google Scholar
• Gillberg C. Deficits in attention, motor control, and perception: a brief review. Arch Dis Child. 2003;88(10):904–910. doi:10.1136/adc.88.10.904
   PubMed Web of Science ®Google Scholar
• Deng S, Li W-G, Ding J, et al. Understanding the mechanisms of cognitive impairments in developmental coordination disorder. Pediatr Res. 2014;75(1–2):210–216. doi:10.1038/pr.2013.192
   Web of Science ®Google Scholar
• Cikriklar HI, Kotan D, Yucel M, et al. The role of orexin-A levels in epileptic seizure. Neurosci Lett. 2020;734:135097. doi:10.1016/j.neulet.2020.135097
   Web of Science ®Google Scholar
• Ozsoy S, Erdem DS, Abdulrezzak U, Basturk M. Serum orexin a and oxytocin levels and their relationships with attachment and childhood trauma in patients with depression. Eur Neuropsychopharm. 2019;29:S374–S375. doi:10.1016/j.euroneuro.2018.11.573
   Web of Science ®Google Scholar
• Portelius E, Soininen H, Andreasson U, et al. Exploring Alzheimer molecular pathology in down’s syndrome cerebrospinal fluid. Neurodegener Dis. 2014;14(2):98–106. doi:10.1159/000358800
   Web of Science ®Google Scholar
• Zhang B, Guo D, Han L, Rensing N, Satoh A, Wong M. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex. Neurobiol Dis. 2020;134:104615. doi:10.1016/j.nbd.2019.104615
   Web of Science ®Google Scholar
• Cataldi M, Arnaldi D, Tucci V, et al. Sleep disorders in Prader-Willi syndrome, evidence from animal models and humans. Sleep Med Rev. 2021;57:101432. doi:10.1016/j.smrv.2021.101432
   PubMed Web of Science ®Google Scholar
• Olateju OI, Bhagwandin A, Ihunwo AO, Manger PR. Changes in the cholinergic, catecholaminergic, orexinergic and serotonergic structures forming part of the sleep systems of adult mice exposed to intrauterine alcohol. Front Neuroanat. 2017;11:110. doi:10.3389/fnana.2017.00110
   Web of Science ®Google Scholar
• Collier AD, Halkina V, Min SS, et al. Embryonic ethanol exposure affects the early development, migration, and location of hypocretin/orexin neurons in zebrafish. Alcohol Clin Exp Res. 2019;43(8):1702–1713. doi:10.1111/acer.14126
   Web of Science ®Google Scholar
• Stettner GM, Kubin L, Volgin DV. Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period. Behav Brain Res. 2011;221(1):324–328. doi:10.1016/j.bbr.2011.03.028
   Web of Science ®Google Scholar
• Gagliano A, Puligheddu M, Ronzano N, et al. Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (pans): from sleep alteration to “brain fog”. Nat Sci Sleep. 2021;13:1209–1224. doi:10.2147/NSS.S300818
   PubMed Web of Science ®Google Scholar
• Wang JY, Han F, Dong SX, et al. Cerebrospinal fluid orexin a levels and autonomic function in Kleine-Levin syndrome. Sleep. 2016;39(4):855–860. doi:10.5665/sleep.5642
   PubMed Web of Science ®Google Scholar
• Moskowitz AK. ”Scared Stiff”: catatonia as an evolutionary-based fear response. Psychol Rev. 2004;111(4):984–1002. doi:10.1037/0033-295X.111.4.984
   PubMed Web of Science ®Google Scholar
• Soya S, Shoji H, Hasegawa E, et al. Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J Neurosci. 2013;33(36):14549–14557. doi:10.1523/JNEUROSCI.1130-13.2013
   PubMed Web of Science ®Google Scholar
• Hansen N, Bartels C, Teegen B, Wiltfang J, Malchow B. Catatonic schizophrenia associated with cerebrospinal gad65 autoantibodies: case report and literature review. Front Immunol. 2022;13:829058. doi:10.3389/fimmu.2022.829058
   Web of Science ®Google Scholar
• McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012;69(2):230–238. doi:10.1001/archneurol.2011.991
   PubMedGoogle Scholar
• Kosse C, Schone C, Bracey E, Burdakov D. Orexin-driven gad65 network of the lateral hypothalamus sets physical activity in mice. Proc Natl Acad Sci U S A. 2017;114(17):4525–4530. doi:10.1073/pnas.1619700114
   Web of Science ®Google Scholar
• Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute covid-19 syndrome. Trends Mol Med. 2021;27(9):895–906. doi:10.1016/j.molmed.2021.06.002
   PubMed Web of Science ®Google Scholar
• Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with covid-19. Nature. 2021;595:283–288.
   PubMed Web of Science ®Google Scholar
• Bileviciute-Ljungar IA-O, Maroti D, Bejerot S. Patients with chronic fatigue syndrome do not score higher on the autism-spectrum quotient than healthy controls: comparison with autism spectrum disorder. Scand J Psychol. 2018;59(4):428–432.
   Web of Science ®Google Scholar
• Miyamae T, Chiba Y, Kato I, Tani Y, Yamanaka H. Neurodevelopmental disorders associated with juvenile fibromyalgia. Pediatr Int. 2018;60:1034–1035.
   Web of Science ®Google Scholar
• Okumura T, Nozu T, Ishioh M, Igarashi S, Kumei S, Ohhira M. Brain orexin improves intestinal barrier function via the vagal cholinergic pathway. Neurosci Lett. 2020;714:134592.
   Web of Science ®Google Scholar
• Mediavilla C. Bidirectional gut-brain communication: a role for orexin-A. Neurochem Int. 2020;141:104882.
   Web of Science ®Google Scholar
• Yilmaz E, Tamam L. Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat. 2018;14:1883–1889.
   Web of Science ®Google Scholar
• Baeza-Velasco C, Grahame R, Bravo JF. A connective tissue disorder may underlie essence problems in childhood. Res Dev Disabil. 2017;60:232–242.
   Web of Science ®Google Scholar
• Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Am Fam Physician. 2021;103:481–492.
   PubMed Web of Science ®Google Scholar
• Kindgren E, Quinones Perez A, Knez R. Prevalence of ADHD and autism spectrum disorder in children with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome: a retrospective study. Neuropsychiatr Dis Treat. 2021;17:379–388.
   Web of Science ®Google Scholar
• Sagi D, de Lecea L, Appelbaum L. Heterogeneity of hypocretin/orexin neurons. Front Neurol Neurosci. 2021;45:61–74.
   Google Scholar
• Kukkonen JP. Orexin/hypocretin signaling. Curr Top Behav Neurosci. 2017;33:17–50.
   Google Scholar
• Dunn GA, Nigg JT, Sullivan EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav. 2019;182:22–34.
   PubMed Web of Science ®Google Scholar
• Keil A, Daniels JL, Forssen U, et al. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology. 2010;21:805–808.
   PubMed Web of Science ®Google Scholar
• Nielsen TC, Nassar N, Shand AW, et al. Association of maternal autoimmune disease with attention-deficit/hyperactivity disorder in children. JAMA Pediatr. 2021;175:e205487.
   Web of Science ®Google Scholar
• McCaffrey TA, St Laurent G, Shtokalo D, et al. Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts. BMC Med Genomics. 2020;13:160.
   Web of Science ®Google Scholar
• Nudel R, Benros ME, Krebs MD, et al. Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders. Eur J Hum Genet. 2019;27:1445–1455.
   Web of Science ®Google Scholar
• Tamouza R, Fernell E, Eriksson MA, et al. Hla polymorphism in regressive and non-regressive autism: a preliminary study. Autism Res. 2020;13:182–186.
   Web of Science ®Google Scholar
• Rout UK, Mungan NK, Dhossche DM. Presence of gad65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry. 2012;21:141–147.
   Web of Science ®Google Scholar
• Bellavance MA, Rivest S. The hpa - immune axis and the immunomodulatory actions of glucocorticoids in the brain. Front Immunol. 2014;5:136.
   PubMed Web of Science ®Google Scholar
• Sehgal A, Mignot E. Genetics of sleep and sleep disorders. Cell. 2011;146:194–207.
   PubMed Web of Science ®Google Scholar
• Ollila HM, Ravel JM, Han F, et al. Hla-dpb1 and hla class i confer risk of and protection from narcolepsy. Am J Hum Genet. 2015;96:136–146.
   PubMed Web of Science ®Google Scholar
• Checa-Ros A, Jerez-Calero A, Molina-Carballo A, Campoy C, Munoz-Hoyos A. Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications. Nutrients. 2021;13:249.
   PubMed Web of Science ®Google Scholar
• Xu M, Xu X, Li J, Li F. Association between gut microbiota and autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry. 2019;10:473.
   PubMed Web of Science ®Google Scholar
• Breugelmans T, De Winter B, Smet A. The microbiota-gut-brain axis in gastrointestinal inflammation and neurological comorbidities. Microb Health Dis. 2019;1:e201.
   Google Scholar
• Gillberg C, Fernell E, Kocovska E, et al. The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: a hypothesis paper. Autism Res. 2017;10:1022–1044.
   Web of Science ®Google Scholar
• Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q. The association between vitamin d deficiency and sleep disorders: a systematic review and meta-analysis. Nutrients. 2018;10:1395.
   Web of Science ®Google Scholar
• Zheng D, Zhao Y, Shen Y, Chang X, Ju S, Guo L. Orexin a-mediated stimulation of 3beta-hsd expression and testosterone production through MAPK signaling pathways in primary rat leydig cells. J Endocrinol Invest. 2014;37:285–292.
   PubMed Web of Science ®Google Scholar
• Rukmani MR, Seshadri SP, Thennarasu K, Raju TR, Sathyaprabha TN. Heart rate variability in children with attention-deficit/hyperactivity disorder: a pilot study. Ann Neurosci. 2016;23:81–88.
   Google Scholar
• Griffiths KR, Quintana DS, Hermens DF, et al. Sustained attention and heart rate variability in children and adolescents with ADHD. Biol Psychol. 2017;124:11–20.
   PubMed Web of Science ®Google Scholar
• Sarovic D. A unifying theory for autism: the pathogenetic triad as a theoretical framework. Front Psychiatry. 2021;12:2081.
   Web of Science ®Google Scholar
• An CE, Nolty AAT, Amano SS, Rizzo AA, Buckwalter JG, Rensberger J. Heart rate variability as an index of resilience. Mil Med. 2020;185:363–369.
   PubMed Web of Science ®Google Scholar
• Carrive P. Orexin, stress and central cardiovascular control A Link with Hypertension?. Neurosci Biobehav Rev. 2017;74:376–392.
   Web of Science ®Google Scholar
• Dergacheva O, Wang X, Huang ZG, et al. Hypocretin-1 (orexin-A) facilitates inhibitory and diminishes excitatory synaptic pathways to cardiac vagal neurons in the nucleus ambiguus. J Pharmacol Exp Ther. 2005;314:1322–1327.
   Web of Science ®Google Scholar
• Li A, Nattie E. Orexin, cardio-respiratory function, and hypertension. Front Neurosci. 2014;8:22.
   Web of Science ®Google Scholar
• Kumar D, Dedic N, Flachskamm C, Deussing J, Kimura M. Cav1.2 calcium channel is involved in the circadian regulation of sleep. Sleep Med. 2013;14:e175.
   Google Scholar
• Buddell T, Friedman V, Drozd CJ, Quinn CC. An autism-causing calcium channel variant functions with selective autophagy to alter axon targeting and behavior. PLoS Genet. 2019;15:e1008488.
   Web of Science ®Google Scholar